to the SEC and publicly disclose the rectified and audited/reviewed financial statements urgently. The SEC found that the auditor gave qualified opinions on EIC’s 2014 and Q1/2015 financial statements
in TL at 96.75 % or 328,950 shares at a par value of 100 baht 2) Approval of the signing of a share purchase agreement for selling ordinary shares in Timelapse Co. Ltd. (“TL”) (the Subsidiary). The
structure. Then, it has been found that the operation of the project in the same manner may result in an inability to acquire the benefits to Company and for shareholders as when the investment was previously
structure. Then, it has been found that the operation of the project in the same manner may result in an inability to acquire the benefits to Company and for shareholders as when the investment was previously
changes in line with the change in revenue. When comparing Q3- 2022 with Q2- 2022, it found that the changed rate of profit higher than the changed rate of revenue. This is because there is no share of loss
”) No.9/2019 Held on November 26, 2019 at 13.30 hrs. has approved investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. Share of
hrs. has approved investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. Share of registered capital total baht 765,000,000 and Paid-up
capital, at Baht 10.50 per share totaling 42,000,000 Baht. (Forty-two million baht), the details are as follows; 1. Date, Month, Year to enter into the transaction On date 9th May 2018. 2. Connected parties
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
business that ORI found its important in order enhance Origin’s financial sustainability and to expand the development of project together with increasing of market share for the company. The joint venture